This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
(HealthDay News) — For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with reduced ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...
Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Nov. 12, 2024 – Most people taking GLP-1 drugs for weight loss or diabetes no longer need to stop taking them before elective surgery, according to new guidance from the American Society of ...
For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...